Clinical Research and Quality Improvement, Department of Surgery, Division of Pediatric Urology, Ann & Robert H. Lurie Children's Hospital, Chicago, IL, USA
Auto-generated profile, based on publicly available information
Ilina Rosoklija
Clinical Research and Quality Improvement, Department of Surgery, Division of Pediatric Urology, Ann & Robert H. Lurie Children's Hospital, Chicago, IL, USA
Current organizational guidelines regarding use of antibiotics during urinary tract catheterization are based on limited evidence and are not directly applicable to the pediatric urology population. We seek to improve understanding of this population by first evaluating current practices. This study aims to investigate practice patterns and attitudes of pediatric urologists regarding the use of antibiotics in the setting of urinary tract catheterization. An online survey was sent to members of the Society for Pediatric Urology. Questionnaire sections included demographics, general questions about antibiotic use with catheterization, and specific clinical scenarios. Descriptive statistics were used, and chi-square analysis was performed to examine associations between demographics and specific responses. Of 448 pediatric urologists surveyed, 154 (34%) responded to the survey. A majority of surveyed urologists (78%) prescribe daily prophylactic antibiotics with a hypospadias stent in place, but extensive variation in use of antibiotics was reported with other catheters and tubes. Extensive variation in practice patterns was also reported for three case scenarios regarding antibiotic prophylaxis with catheterization. Urologists > 50 years of age and fellowship-trained urologists were more likely to prescribe antibiotics for hypospadias stents (p = 0.02, p = 0.03), but no other significant associations between demographic characteristics and antibiotic use were found. There is substantial variation in practice patterns among surveyed pediatric urologists regarding prophylactic antibiotic use with urinary catheterization. This variation, combined with a lack of objective data and increasing pressure to decrease infectious complications and combat antibiotic resistance, highlights the need for development of management guidelines for this unique population.
Purpose Little is known about phenotypes, diagnoses and sex of rearing (SR) of infants with atypical genital development in the United States. As part of a multi-center study of these infants, we provide a baseline report from US difference/disorder of sex development (DSD) clinics describing diagnoses, anatomic features and SR. We also aim to determine whether Consensus guidelines are followed for sex designation in the US. Methods Eligible participants had moderate-to-severe genital atypia, age <3 years and no prior genitoplasty. Karyotype, genetic diagnosis, DSD etiology, family history and SR were collected. Standardized exam was performed. Results Of 92 subjects, karyotypes were: 57% 46,XX, 34% 46,XY, and 9% sex chromosome abnormality. Median age at baseline evaluation was 8.8 months. Most 46,XX subjects had congenital adrenal hyperplasia (CAH) (91%) and most 46,XY subjects (65%) did not have a known diagnosis. Two individuals with CAH underwent a change in SR from male to female within 2 weeks of birth. Presence of a uterus and shorter phallic length were associated with female SR. The most common karyotype and diagnosis was 46,XX with CAH followed by 46,XY with unknown diagnosis. Phenotypically, atypical genitalia are most commonly characterized by abnormal labioscrotal tissue, phallic length and urethral meatus location. Conclusions Increased phallic length was positively associated with rearing male. Among US centers studied, sex designation followed Consensus Statement recommendations. Further study is needed to determine if this results in patient satisfaction.